CONMED Historical Balance Sheet

CNMD Stock

USD 59.64 0.68 1.15%

Trend analysis of CONMED balance sheet accounts such as Short Long Term Debt Total of 951.1 M, Other Current Liabilities of 183.9 M or Total Current Liabilities of 292 M provides information on CONMED's total assets, liabilities, and equity, which is the actual value of CONMED to its prevalent stockholders. By breaking down trends over time using CONMED balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining CONMED latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CONMED is a good buy for the upcoming year.

CONMED Inventory

364.05 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

About CONMED Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CONMED at a specified time, usually calculated after every quarter, six months, or one year. CONMED Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CONMED and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CONMED currently owns. An asset can also be divided into two categories, current and non-current.

CONMED Balance Sheet Chart

At present, CONMED's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 183.9 M, whereas Cash is forecasted to decline to about 17.4 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Non Currrent Assets Other

Add Fundamental

Total Assets

Total assets refers to the total amount of CONMED assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CONMED books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on CONMED balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CONMED are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most accounts from CONMED's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CONMED current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.At present, CONMED's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 183.9 M, whereas Cash is forecasted to decline to about 17.4 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.1B	991.3M	905.8M	951.1M
Total Assets	2.3B	2.3B	2.3B	2.4B

Short Long Term Debt Total Total Assets

CONMED balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Good Will	Common Stock Total Equity
Total Assets		0.95	0.79	0.98	0.93	0.34	0.95	0.83	-0.09	0.99	0.71	-0.09	0.95	0.68	0.98	0.94	0.81	0.97	0.98	0.86	0.95	0.19	0.87	0.95	0.9	0.67
Short Long Term Debt Total	0.95		0.68	0.93	0.78	0.11	1.0	0.67	-0.24	0.97	0.67	-0.23	0.84	0.51	0.99	0.85	0.68	0.87	0.99	0.79	0.82	0.25	0.88	0.92	0.93	0.47
Other Current Liab	0.79	0.68		0.84	0.77	0.31	0.67	0.6	0.0	0.75	0.58	0.0	0.76	0.52	0.73	0.88	0.7	0.86	0.76	0.87	0.86	0.04	0.57	0.75	0.66	0.51
Total Current Liabilities	0.98	0.93	0.84		0.88	0.28	0.93	0.74	-0.14	0.96	0.67	-0.14	0.92	0.62	0.95	0.96	0.8	0.96	0.97	0.89	0.95	0.27	0.83	0.94	0.89	0.6
Total Stockholder Equity	0.93	0.78	0.77	0.88		0.55	0.77	0.96	0.07	0.9	0.66	0.07	0.98	0.81	0.82	0.89	0.84	0.96	0.84	0.79	0.96	0.07	0.73	0.87	0.74	0.85
Property Plant And Equipment Net	0.34	0.11	0.31	0.28	0.55		0.08	0.64	0.59	0.29	0.16	0.58	0.49	0.88	0.19	0.3	0.48	0.4	0.21	0.15	0.47	0.18	0.38	0.13	0.23	0.89
Net Debt	0.95	1.0	0.67	0.93	0.77	0.08		0.65	-0.28	0.97	0.69	-0.28	0.83	0.49	0.99	0.84	0.65	0.86	0.98	0.79	0.81	0.25	0.87	0.92	0.93	0.44
Retained Earnings	0.83	0.67	0.6	0.74	0.96	0.64	0.65		0.2	0.8	0.58	0.2	0.92	0.86	0.71	0.75	0.79	0.85	0.72	0.62	0.86	0.0	0.68	0.76	0.63	0.91
Cash	-0.09	-0.24	0.0	-0.14	0.07	0.59	-0.28	0.2		-0.15	-0.43	1.0	-0.02	0.33	-0.16	-0.06	0.34	-0.08	-0.16	-0.16	0.1	-0.15	0.02	-0.22	-0.19	0.4
Non Current Assets Total	0.99	0.97	0.75	0.96	0.9	0.29	0.97	0.8	-0.15		0.73	-0.15	0.93	0.65	0.99	0.91	0.76	0.95	0.99	0.83	0.91	0.2	0.88	0.94	0.92	0.63
Non Currrent Assets Other	0.71	0.67	0.58	0.67	0.66	0.16	0.69	0.58	-0.43	0.73		-0.43	0.67	0.45	0.69	0.62	0.37	0.71	0.69	0.57	0.59	-0.01	0.52	0.67	0.65	0.43
Cash And Short Term Investments	-0.09	-0.23	0.0	-0.14	0.07	0.58	-0.28	0.2	1.0	-0.15	-0.43		-0.02	0.33	-0.16	-0.06	0.34	-0.07	-0.16	-0.15	0.1	-0.15	0.02	-0.22	-0.19	0.4
Net Receivables	0.95	0.84	0.76	0.92	0.98	0.49	0.83	0.92	-0.02	0.93	0.67	-0.02		0.78	0.87	0.89	0.81	0.96	0.89	0.78	0.94	0.09	0.8	0.91	0.8	0.8
Common Stock Shares Outstanding	0.68	0.51	0.52	0.62	0.81	0.88	0.49	0.86	0.33	0.65	0.45	0.33	0.78		0.56	0.6	0.67	0.7	0.58	0.47	0.73	0.23	0.71	0.5	0.62	0.96
Non Current Liabilities Total	0.98	0.99	0.73	0.95	0.82	0.19	0.99	0.71	-0.16	0.99	0.69	-0.16	0.87	0.56		0.89	0.73	0.9	1.0	0.82	0.87	0.24	0.89	0.93	0.93	0.53
Inventory	0.94	0.85	0.88	0.96	0.89	0.3	0.84	0.75	-0.06	0.91	0.62	-0.06	0.89	0.6	0.89		0.86	0.97	0.91	0.94	0.97	0.21	0.72	0.92	0.79	0.62
Other Current Assets	0.81	0.68	0.7	0.8	0.84	0.48	0.65	0.79	0.34	0.76	0.37	0.34	0.81	0.67	0.73	0.86		0.84	0.75	0.79	0.92	0.04	0.66	0.79	0.63	0.71
Other Stockholder Equity	0.97	0.87	0.86	0.96	0.96	0.4	0.86	0.85	-0.08	0.95	0.71	-0.07	0.96	0.7	0.9	0.97	0.84		0.92	0.89	0.98	0.15	0.76	0.94	0.82	0.72
Total Liab	0.98	0.99	0.76	0.97	0.84	0.21	0.98	0.72	-0.16	0.99	0.69	-0.16	0.89	0.58	1.0	0.91	0.75	0.92		0.84	0.89	0.24	0.89	0.93	0.93	0.55
Property Plant And Equipment Gross	0.86	0.79	0.87	0.89	0.79	0.15	0.79	0.62	-0.16	0.83	0.57	-0.15	0.78	0.47	0.82	0.94	0.79	0.89	0.84		0.88	0.12	0.64	0.87	0.74	0.45
Total Current Assets	0.95	0.82	0.86	0.95	0.96	0.47	0.81	0.86	0.1	0.91	0.59	0.1	0.94	0.73	0.87	0.97	0.92	0.98	0.89	0.88		0.15	0.75	0.9	0.77	0.76
Short Term Debt	0.19	0.25	0.04	0.27	0.07	0.18	0.25	0.0	-0.15	0.2	-0.01	-0.15	0.09	0.23	0.24	0.21	0.04	0.15	0.24	0.12	0.15		0.3	0.04	0.31	0.14
Intangible Assets	0.87	0.88	0.57	0.83	0.73	0.38	0.87	0.68	0.02	0.88	0.52	0.02	0.8	0.71	0.89	0.72	0.66	0.76	0.89	0.64	0.75	0.3		0.76	0.96	0.63
Accounts Payable	0.95	0.92	0.75	0.94	0.87	0.13	0.92	0.76	-0.22	0.94	0.67	-0.22	0.91	0.5	0.93	0.92	0.79	0.94	0.93	0.87	0.9	0.04	0.76		0.82	0.53
Good Will	0.9	0.93	0.66	0.89	0.74	0.23	0.93	0.63	-0.19	0.92	0.65	-0.19	0.8	0.62	0.93	0.79	0.63	0.82	0.93	0.74	0.77	0.31	0.96	0.82		0.53
Common Stock Total Equity	0.67	0.47	0.51	0.6	0.85	0.89	0.44	0.91	0.4	0.63	0.43	0.4	0.8	0.96	0.53	0.62	0.71	0.72	0.55	0.45	0.76	0.14	0.63	0.53	0.53

Click cells to compare fundamentals

CONMED Account Relationship Matchups

CONMED balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8B	1.8B	2.3B	2.3B	2.3B	2.4B
Short Long Term Debt Total	775.9M	684.7M	1.1B	991.3M	905.8M	951.1M
Other Current Liab	111.0M	126.2M	153.4M	214.3M	175.2M	183.9M
Total Current Liabilities	190.2M	196.6M	296.6M	310.7M	278.1M	292.0M
Total Stockholder Equity	709.0M	785.4M	745.5M	834.2M	962.7M	1.0B
Property Plant And Equipment Net	111.4M	108.9M	115.6M	120.7M	115.8M	93.3M
Net Debt	748.5M	663.8M	1.0B	967.0M	881.3M	925.4M
Retained Earnings	457.4M	496.6M	412.6M	452.5M	560.3M	588.3M
Cash	27.4M	20.8M	28.9M	24.3M	24.5M	17.4M
Non Current Assets Total	1.3B	1.3B	1.7B	1.7B	1.7B	1.7B
Non Currrent Assets Other	96.8M	98.8M	93.9M	96.1M	116.4M	122.2M
Cash And Short Term Investments	27.4M	20.8M	28.9M	24.3M	24.5M	17.8M
Net Receivables	177.2M	183.9M	191.3M	242.3M	237.7M	249.6M
Common Stock Shares Outstanding	29.5M	32.2M	30.0M	31.5M	31.1M	26.1M
Liabilities And Stockholders Equity	1.8B	1.8B	2.3B	2.3B	2.3B	2.4B
Non Current Liabilities Total	852.4M	783.9M	1.3B	1.2B	1.1B	1.1B
Inventory	194.9M	231.6M	332.3M	318.3M	346.7M	364.1M
Other Current Assets	17.3M	23.8M	28.6M	30.8M	31.1M	32.7M
Other Stockholder Equity	315.0M	342.7M	390.5M	431.5M	461.3M	484.3M
Total Liab	1.0B	980.6M	1.6B	1.5B	1.3B	1.4B
Property Plant And Equipment Gross	111.4M	372.6M	393.1M	412.9M	421.2M	442.3M
Total Current Assets	416.7M	460.1M	581.2M	615.6M	640.0M	672.0M
Accumulated Other Comprehensive Income	(63.7M)	(54.2M)	(57.9M)	(50.2M)	(58.9M)	(55.9M)
Short Term Debt	25.9M	12.2M	69.7M	8.2M	715K	679.3K
Intangible Assets	501.5M	471.0M	681.8M	649.5M	617.7M	341.4M
Accounts Payable	53.3M	58.2M	73.4M	88.2M	102.2M	107.4M
Good Will	618.4M	617.5M	815.4M	806.8M	805.4M	445.9M
Other Liab	104.2M	102.5M	98.8M	258.7M	297.5M	312.3M
Other Assets	84.9M	103.6M	89.0M	85.8M	98.7M	103.6M
Long Term Debt	734.8M	672.4M	985.1M	973.1M	905.1M	950.3M
Treasury Stock	(80.7M)	(67.6M)	(54.1M)	(22.8M)	(20.5M)	(21.5M)
Property Plant Equipment	118.9M	111.4M	108.9M	115.6M	133.0M	129.3M
Current Deferred Revenue	50.2M	60.5M	9.7M	(8.2M)	(9.4M)	(9.0M)
Net Tangible Assets	(440.4M)	(410.9M)	(340.8M)	(751.7M)	(676.5M)	(642.7M)
Retained Earnings Total Equity	470.8M	457.4M	496.6M	412.6M	474.5M	467.3M
Long Term Debt Total	755.2M	735.2M	672.4M	985.1M	1.1B	1.2B
Capital Surpluse	379.3M	382.6M	396.8M	413.2M	475.2M	384.5M
Deferred Long Term Liab	74.5M	57.9M	68.5M	66.7M	60.1M	72.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:

How To Invest In CONMED

Details

Is CONMED Stock a good investment?

Details

What is CONMED's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.028

Dividend Share

0.8

Earnings Share

4.25

Revenue Per Share

42.372

Quarterly Revenue Growth

0.058

The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CONMED Historical Balance Sheet

CONMED Inventory

364.05 Million

About CONMED Balance Sheet Analysis

CONMED Balance Sheet Chart

Total Assets

Total Current Liabilities

Non Currrent Assets Other

CONMED balance sheet Correlations

CONMED Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CONMED balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total

Cash And Short Term Investments	- 0.43	Non Currrent Assets Other
Non Currrent Assets Other	- 0.43	Cash
Cash And Short Term Investments	- 0.28	Net Debt
Cash	- 0.28	Net Debt
Cash	- 0.24	Short Long Term Debt Total
Cash And Short Term Investments	- 0.23	Short Long Term Debt Total